rs12943590
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs12943590(A;A) |
| Make rs12943590(A;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 17 |
| Position | 19716685 |
| Gene | SLC47A2 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs12943590 |
| dbSNP (classic) | rs12943590 |
| ClinGen | rs12943590 |
| ebi | rs12943590 |
| HLI | rs12943590 |
| Exac | rs12943590 |
| Gnomad | rs12943590 |
| Varsome | rs12943590 |
| LitVar | rs12943590 |
| Map | rs12943590 |
| PheGenI | rs12943590 |
| Biobank | rs12943590 |
| 1000 genomes | rs12943590 |
| hgdp | rs12943590 |
| ensembl | rs12943590 |
| geneview | rs12943590 |
| scholar | rs12943590 |
| rs12943590 | |
| pharmgkb | rs12943590 |
| gwascentral | rs12943590 |
| openSNP | rs12943590 |
| 23andMe | rs12943590 |
| SNPshot | rs12943590 |
| SNPdbe | rs12943590 |
| MSV3d | rs12943590 |
| GWAS Ctlg | rs12943590 |
| GMAF | 0.3039 |
| Max Magnitude | 0 |
[PMID 23267855
] The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
| ClinVar | |
|---|---|
| Risk | rs12943590(A;A) |
| Alt | rs12943590(A;A) |
| Reference | Rs12943590(G;G) |
| Significance | Drug-response |
| Disease | metformin response - Efficacy |
| Variation | info |
| Gene | SLC47A2 |
| CLNDBN | metformin response - Efficacy |
| Reversed | 0 |
| HGVS | NC_000017.10:g.19619998G>A |
| CLNSRC | PharmGKB Clinical Annotation |
| CLNACC | RCV000211313.1, |
